Viatris (VTRS) Accounts Payables (2019 - 2026)
Viatris (VTRS) posted quarterly Accounts Payables of $1.7 billion for Q1 2026, down 12.02% year-over-year from $2.0 billion in Q1 2025, and little changed quarter-over-quarter from $1.8 billion in Q4 2025.
Viatris (VTRS) Accounts Payables (2019 - 2026) Analysis & Trends
Viatris' Accounts Payables history runs 8 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- In Q1 2026, Accounts Payables fell 12.02% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (down 12.02% YoY), while the FY2025 annual figure was $1.8 billion, down 5.37% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.7 billion, roughly flat from $1.8 billion in the prior quarter.
- The five-year high for Accounts Payables was $2.2 billion in Q1 2024, with the low at $1.3 billion in Q3 2022.
- The 5-year median for Accounts Payables is $1.9 billion (2024), against an average of $1.8 billion.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables declined 26.61% in 2022, then surged 51.78% in 2023.
- Viatris' Accounts Payables stood at $1.8 billion in 2022, then gained by 9.71% to $1.9 billion in 2023, then retreated by 4.36% to $1.9 billion in 2024, then fell by 5.37% to $1.8 billion in 2025, then slipped by 0.27% to $1.7 billion in 2026.
- Business Quant data shows VTRS's Accounts Payables at $1.7 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Bn |
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.75 Bn |
| Sep 30, 2025 | 1.79 Bn |
| Jun 30, 2025 | 1.78 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.85 Bn |
| Sep 30, 2024 | 1.93 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 2.20 Bn |
| Dec 31, 2023 | 1.94 Bn |
| Sep 30, 2023 | 1.99 Bn |
| Jun 30, 2023 | 1.96 Bn |
| Mar 31, 2023 | 1.96 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.31 Bn |
| Jun 30, 2022 | 1.67 Bn |
| Mar 31, 2022 | 1.50 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Sep 30, 2021 | 1.66 Bn |